Bio-Techne (TECH) FCF Payout Ratio Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Bio-Techne | 7.92 Bn | 7.71 Bn | 208.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.58% |
| Dec 31, 2025 | 0.47% |
| Sep 30, 2025 | 20.11% |
| Jun 30, 2025 | -21.56% |
| Mar 31, 2025 | 5.84% |
| Dec 31, 2024 | -5.53% |
| Sep 30, 2024 | -10.57% |
| Jun 30, 2024 | -4.34% |
| Mar 31, 2024 | -10.94% |
| Dec 31, 2023 | -8.57% |
| Sep 30, 2023 | -4.19% |
| Jun 30, 2023 | -3.16% |
| Mar 31, 2023 | -13.27% |
| Dec 31, 2022 | -10.00% |
| Sep 30, 2022 | -2.33% |
| Jun 30, 2022 | -11.28% |
| Mar 31, 2022 | -17.54% |
| Dec 31, 2021 | -14.77% |
| Sep 30, 2021 | -9.87% |
| Jun 30, 2021 | -20.52% |
| Mar 31, 2021 | -11.01% |
| Dec 31, 2020 | -14.75% |
| Sep 30, 2020 | -13.50% |
| Jun 30, 2020 | 2.58% |
| Mar 31, 2020 | -7.84% |
| Dec 31, 2019 | -9.72% |
| Sep 30, 2019 | 1.72% |
| Jun 30, 2019 | -3.07% |
| Mar 31, 2019 | -1.38% |
| Dec 31, 2018 | -6.96% |
| Sep 30, 2018 | -2.28% |
| Jun 30, 2018 | -14.59% |
| Mar 31, 2018 | 9.78% |
| Dec 31, 2017 | -5.29% |
| Sep 30, 2017 | -4.68% |
| Jun 30, 2017 | -2.08% |
| Mar 31, 2017 | 12.62% |
| Dec 31, 2016 | -11.53% |
| Sep 30, 2016 | 10.52% |
| Jun 30, 2016 | 3.38% |
| Mar 31, 2016 | 1.94% |
| Dec 31, 2015 | 0.29% |
| Sep 30, 2015 | 7.33% |
| Jun 30, 2015 | 4.48% |
| Mar 31, 2015 | 0.70% |
| Dec 31, 2014 | 0.03% |
| Sep 30, 2014 | 1.89% |